Gumesad, Miah Blaise L.
HRN: 19-40-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
CEFUROXIME 750MG (VIAL)
08/31/2023
09/06/2023
IV
500mg
Q8h
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes